F. HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124 – Basel – 4070
VAT: CHE116267986MWST
http://www.roche.com
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, F. HOFFMANN-LA ROCHE AG has received € 0.0 for its participation in a total of 6 project(s) with a total cost of € 198,482,280.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | 101007939 | RealHOPE | proteins · pharmacology and pharmacy | 2025-06-30 | participant | € 0.0 | € 7,132,608 | 1 | 27 | CORDIS ↪ |
| 2021-10-01 | 101034427 | SCREEN4CARE | family planning · genomes | 2026-09-30 | participant | € 0.0 | € 25,423,568 | 1 | 37 | CORDIS ↪ |
| 2020-01-01 | 853992 | PharmaLedger | governance · big data · cryptography · business intelligence · health care services | 2022-12-31 | participant | € 0.0 | € 22,118,324 | 2 | 30 | CORDIS ↪ |
| 2017-10-01 | 777364 | EQIPD | neurobiology · data science · alzheimer · governance · machine learning | 2021-09-30 | participant | € 0.0 | € 9,360,691 | 1 | 31 | CORDIS ↪ |
| 2021-11-01 | 101034344 | EPND | neurobiology · data science · alzheimer · parkinson | 2026-10-31 | participant | € 0.0 | € 19,005,502 | 1 | 29 | CORDIS ↪ |
| 2018-06-01 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | 2025-05-31 | participant | € 0.0 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, F. HOFFMANN-LA ROCHE AG has received € 0.0 for its participation in a total of 1 project(s) with a total cost of € 145,830,619.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-01 | 101156595 | ERDERA | ecosystems | 2031-08-31 | associatedPartner | € nan | € 145,830,619 | 2 | 178 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, F. HOFFMANN-LA ROCHE AG has received € 124,246.0 for its participation in a total of 8 project(s) with a total cost of € 195,269,197.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-02-01 | 115188 | PREDECT | bioreactors · lung cancer | 2016-04-30 | participant | € nan | € 21,020,760 | 1 | 21 | CORDIS ↪ |
| 2009-06-15 | 115003 | SAFE-T | data science · databases · pathology · modeling of diseases spread | 2015-06-14 | participant | € nan | € 36,427,294 | 1 | 26 | CORDIS ↪ |
| 2008-04-01 | 201619 | ESNATS | drug discovery · proteomics · automation · stem cells · toxicology | 2013-09-30 | participant | € nan | € 15,592,219 | 1 | 33 | CORDIS ↪ |
| 2011-03-01 | 115156 | DDMORE | ontology · software · public health · ecosystems · mathematical model | 2016-08-31 | participant | € nan | € 23,063,274 | 1 | 28 | CORDIS ↪ |
| 2014-02-01 | 603196 | PSYSCAN | psychiatry · machine learning | 2020-01-31 | participant | € 124,246.95 | € 8,336,818 | 1 | 22 | CORDIS ↪ |
| 2009-09-01 | 115008 | NEWMEDS | drug discovery · cognitive neuroscience · pharmaceutical drugs · schizophrenia · machine learning | 2015-02-28 | participant | € nan | € 24,849,675 | 1 | 20 | CORDIS ↪ |
| 2012-10-01 | 115439 | STEMBANCC | neurobiology · drug discovery · diabetes · stem cells · toxicology | 2018-03-31 | coordinator | € nan | € 55,010,480 | 2 | 38 | CORDIS ↪ |
| 2014-10-01 | 115618 | DRIVE-AB | drug discovery · public health · databases · antibiotics · antibiotic resistance | 2017-12-31 | participant | € nan | € 10,968,676 | 1 | 23 | CORDIS ↪ |